Cc-5013\Placebo


Indications and Reactions:

Role Indications Reactions
Primary
Prostate Cancer 34.6%
Drug Use For Unknown Indication 9.7%
Multiple Myeloma 9.0%
Product Used For Unknown Indication 8.0%
Hypertension 7.0%
Pain 5.1%
Prophylaxis 3.6%
Constipation 3.2%
Thrombosis Prophylaxis 2.8%
Rash 2.6%
Proteus Infection 2.2%
Pseudomonas Infection 2.2%
Gout 1.6%
Supplementation Therapy 1.4%
Atrial Flutter 1.3%
Bone Pain 1.3%
Analgesic Therapy 1.2%
Infection Prophylaxis 1.2%
Nausea 1.2%
Atrial Fibrillation 1.0%
Pneumonia 9.4%
Pyrexia 9.4%
Sepsis 9.4%
Neutropenia 7.8%
Pain 6.3%
Renal Failure Acute 6.3%
Bradyarrhythmia 4.7%
General Physical Health Deterioration 4.7%
Hypocalcaemia 4.7%
Peritonitis 4.7%
Squamous Cell Carcinoma 4.7%
Death 3.1%
Dyskinesia 3.1%
Gastrointestinal Haemorrhage 3.1%
Gastrointestinal Perforation 3.1%
Haemolysis 3.1%
Haemolytic Anaemia 3.1%
Hypovolaemic Shock 3.1%
Lower Respiratory Tract Infection 3.1%
Lung Disorder 3.1%
Secondary
Prostate Cancer 31.9%
Product Used For Unknown Indication 9.9%
Multiple Myeloma 7.3%
Hypertension 5.9%
Pain 5.7%
Prophylaxis 4.6%
Constipation 4.2%
Rash 4.0%
Thrombosis Prophylaxis 4.0%
Proteus Infection 3.3%
Pseudomonas Infection 3.3%
Drug Use For Unknown Indication 3.1%
Infection Prophylaxis 2.2%
Atrial Flutter 2.0%
Supplementation Therapy 2.0%
Nausea 1.8%
Atrial Fibrillation 1.3%
Cough 1.3%
Depression 1.3%
Bacterial Infection 1.1%
Sepsis 15.1%
Pyrexia 13.2%
Neutropenia 7.5%
General Physical Health Deterioration 5.7%
Peritonitis 5.7%
Squamous Cell Carcinoma 5.7%
Basal Cell Carcinoma 3.8%
Dehydration 3.8%
Dyskinesia 3.8%
Gastrointestinal Perforation 3.8%
Haemolysis 3.8%
Haemolytic Anaemia 3.8%
Lung Disorder 3.8%
Mucosal Inflammation 3.8%
Performance Status Decreased 3.8%
Peripheral Ischaemia 3.8%
Urinary Tract Infection 3.8%
Acute Respiratory Failure 1.9%
Alveolitis Allergic 1.9%
Arrhythmia 1.9%

Drug Data